Records containing: Leukemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-28Observational Cohort Study of People Living With HIV Treated With CD19-directed CAR T Cell Therapy for B-cell Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2026-10-06Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha/Beta T-Cell and B-Cell Depletion for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-27Natural History Study of Early Life Exposures in Agriculture (ELEA)
-
CLINICAL_TRIALS study record update · 2026-04-27A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia
-
CLINICAL_TRIALS study record update · 2026-04-27Phase II Haploidentical Hematopoietic Stem Cell Transplantation for Participants With Germline RUNX1 Associated Hematologic Malignancies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-27A Phase I Trial of Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
-
CLINICAL_TRIALS study record update · 2026-04-27Investigation of the Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
-
CLINICAL_TRIALS study record update · 2026-04-24A Case-Control Study of Pesticides and Childhood Leukemia
-
CLINICAL_TRIALS study record update · 2026-04-24Phase II Haploidentical Hematopoietic Stem Cell Transplantation for Participants With Germline RUNX1 Associated Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-24Natural History Study of Early Life Exposures in Agriculture (ELEA)
-
CLINICAL_TRIALS study record update · 2026-04-24Investigation of the Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
-
CLINICAL_TRIALS study record update · 2026-04-23Managed Access Programs for CTL019, Tisagenlecleucel
-
CLINICAL_TRIALS study record update · 2026-04-23Phase II Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
-
CLINICAL_TRIALS study record update · 2026-04-21Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy: The PEACE Study
-
CLINICAL_TRIALS study record update · 2026-04-20Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
-
CLINICAL_TRIALS study record update · 2026-04-20Study of Biomarkers of Exposure and Effects in Agriculture
-
CLINICAL_TRIALS study record update · 2026-04-20Expression of the Genome in Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase Ib/II, Single Center, Open-Label, Safety and Efficacy Study to Improve Anemia in Subjects on Enasidenib With Lower Risk Myelodysplastic Syndrome and Non-proliferative Chronic Myelomonocytic Leukemia Without an IDH2 Mutation
-
CLINICAL_TRIALS study record update · 2026-04-16An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Ponatinib for the Treatment of Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors in Pediatric Participants
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase I/IIa Trial For The Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
-
CLINICAL_TRIALS study record update · 2026-04-16Pre-malignant States to Hematologic Malignancies in Firefighters
-
CLINICAL_TRIALS study record update · 2026-04-15Phase 1/2 Study: CD45RA Depleted Peripheral Stem Cell Addback to Prevent Viral and Fungal Infections Following Alternative Donor TCRab/CD19 Depleted Hematopoietic Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2026-04-14Phase 1 Study to Determine the Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-rearranged or NPM1-mutant Relapsed/Refractory Acute Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2026-04-09An Open, Multi-center, Randomized Trial Comparing Haploidentical HSCTs From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-09A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine